January 08, 2025 06:11 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Sheesh Mahal row: AAP leaders who were denied entry into CM's residence turn towards PM's house | Anna University sexual assault accused is a DMK supporter, not member: MK Stalin | Ajit Doval, Raja Dato discuss bilateral cooperation during India-Malaysia Security Dialogue | US President-elect Donald Trump threatens to use economic force to make Canada 51st US State, Justin Trudeau retorts sharply | Elon Musk raises concern on 'world population decline' including that of India, China | Indian-origin Anita Ananda might replace Justin Trudeau as Canadian PM | 'I won't bite': Kamala Harris tells Senator's husband as he refuses to shake hands with her | Centre announces memorial for Pranab Mukherjee, his daughter thanks PM Modi for 'gracious gesture' | Delhi assembly elections on Feb 5, results on Feb 8 | Allu Arjun visits boy injured during Pushpa 2 stampede in Hyderabad

India crosses the milestone of conducting 400 million Covid tests

Jun 27, 2021, at 01:22 am

New Delhi/IBNS: India crossed the milestone of 400 million Covid-19 tests on Friday, with the last 50 million tests being done in the last 24 days, according to the Indian Council of Medical Research (ICMR).

People in England to be offered twice-weekly rapid COVID-19 tests: UK Prime Minister

Apr 05, 2021, at 11:23 pm

London/Sputnik: People in England will be offered rapid COVID-19 tests twice a week from April 9, as part of the UK government's plan to stop the spread of the coronavirus SARS-CoV-2 and reopen business and society, UK Prime Minister Boris Johnson announced on Monday.

New COVID-19 test gives result in matter of minutes: Report

Jan 05, 2021, at 09:12 pm

London: A new COVID-19 test that reduces testing time from 30 minutes to less than five and delivers accurate results has been developed by researchers at the University of Birmingham.

DCGI approves Tata Group's low cost CRISPR Covid-19 test 'Feluda'

Sep 21, 2020, at 07:55 am

Delhi/IBNS: The Drugs Controller General of India (DCGI) has given its approval for the commercial launch of India's first Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Covid-19 test 'Feluda' developed by the Tata Group and CSIR-IGIB (Institute of Genomics and Integrative Biology).